Clinical Trial Update: Safety and Immunogenicity of 3 Lots of GSK Biologicals' HBV-MPL Vaccine and Engerix™-B in Healthy Volunteers ≥ 15y [Phase 3]

View source ↗

Summary

This Phase 3 trial completed, evaluating the safety and immunogenicity of three lots of GSK's HBV-MPL vaccine together with Engerix-B in healthy volunteers aged…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Engerix-B (hepatitis B vaccine)
• HBV-MPL vaccine (HBV-MPL vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis B | Phase 3 | Status: COMPLETED